# Owner raises $240M Series D led by Goldman Sachs Alternatives

> Owner, based in United States, has raised $240M in a Series D led by Goldman Sachs Alternatives, announced on 28 August 2026. 7 other investors joined.

Source: https://millionrounds.com/news/rounds/owner-series-d-2026-08 (Millionrounds; every figure on the page links to its filing or article)

Raised **$240M** 2 sources reported it

Stage **Series D** 2 earlier rounds on record

Investors **8** 1 named as lead

Where **US** United States

AI B2B Food & Beverage Martech

## How big is it?

Against every equity round we recorded in the twelve months to 28 August 2026. Ranks count companies, so the same raise reported twice is counted once.

**#219** equity round of the last twelve months

**#28** Series D of 75 in that time

**#155** round in United States, of 1,111

This round **$240M**

Median Series D **$160M**

1.5 times the median Series D of the last twelve months.

## Who invested

- [**Goldman Sachs Alternatives** 16 rounds in the last twelve months *Led*](https://millionrounds.com/fund/goldman-sachs-alternatives)

Also in the round

- [Y Combinator](https://millionrounds.com/fund/y-combinator)
- [Goldman Sachs](https://millionrounds.com/fund/goldman-sachs)
- [Redpoint](https://millionrounds.com/fund/redpoint)
- [Headline](https://millionrounds.com/fund/headline)
- [9Yards Capital](https://millionrounds.com/fund/9yards-capital)
- [Meritech Capital Partners](https://millionrounds.com/fund/meritech-capital-partners)
- [Jack Altman](https://millionrounds.com/fund/jack-altman)

## Funding history

- August 2026 Series D **$240M**
- May 2025 Series C **$120M**
- December 2024 Round **Undisclosed**

$360M raised across the 3 rounds we hold.

## Reported by

- Ventureburn 28 August
- GTMfund 28 August

The round's figures come from these reports; each link opens the original.

## Other big rounds that week

[**Instinct** $250M Series B](https://millionrounds.com/news/rounds/instinct-series-b-2026-08)[A **AusperBio Therapeutics** $120M Series C](https://millionrounds.com/news/rounds/ausperbio-therapeutics-series-c-2026-08)[**Generalist** $200M Series B](https://millionrounds.com/news/rounds/generalist-series-b-2026-08)[**Gatik** $200M Series D](https://millionrounds.com/news/rounds/gatik-series-d-2026-08)[**Emerald AI** $150M Series A](https://millionrounds.com/news/rounds/emerald-ai-series-a-2026-08)[**General Intuition** $220M Growth](https://millionrounds.com/news/rounds/general-intuition-growth-round-2026-08)

[The company **Owner on Millionrounds** *→*](https://millionrounds.com/company/owner)[Weekly roundup **Week of 24 August** *→*](https://millionrounds.com/news/weekly/2026-08-24)[Monthly roundup **August 2026** *→*](https://millionrounds.com/news/monthly/2026-08)

**How this article is made**

We write one for every equity round of $100M or more that at least two sources reported. It is put together from our record of rounds, not rewritten from the reports: the ranks and medians count every equity round we read in the twelve months to the round's date. [How we read rounds](https://millionrounds.com/methodology) · [Report a mistake](https://millionrounds.com/corrections)